In this discussion, Heather Burrell-Ward, M.D., provides an overview of her recent study that found TMS aimed at the default mode network improved processing speed in schizophrenia.

Biosimilars can cost $600 a month versus $6,000 for branded rivals, but PBM rebate incentives push formularies toward pricier ...

CMS’ mandatory GLOBE drug model ties some Medicare Part B rebates to global prices, but cuts projected savings sharply amid ...

Teledentistry has become an important tool for helping patients access dental expertise when and where they need it. It can ...

Some predicted that drugmakers might boost launch prices to make up for Medicare drug negotiations shrinking profits. Harvard ...

State PBM reform accelerates through 2026, with Theresa Carnegie of Mintz unpacking new laws, rebate pass-through, spread ...

Tariffs on patented drugs broaden beyond Big Pharma, and exemptions, MFN deals and origin caps determine rates and potential ...

In this discussion, Ohio State economist Eric Seiber, Ph.D., explains how inconsistent claims-data definitions can skew ...

The newest wave of cancer therapies, including CAR-T cell therapy, bispecific antibodies and antibody-drug conjugates, is ...

Meta-analysis of 13 RCTs (2002–2024; eight countries) found VR reduced pain (SMD −0.76) and anxiety (SMD −1.53), largely ...

Fewer than one in five young people with first episode psychosis filled enough antipsychotic prescriptions to be considered ...

Employers that decide to stop covering GLP-1s for weight loss are increasingly pairing that decision with support for the ...